[go: up one dir, main page]

ECSP11011212A - Nueva asociación de ingredientes activos que contienen un fármaco antiinflamatorio, no esteroideo y un derivado de colchicósido - Google Patents

Nueva asociación de ingredientes activos que contienen un fármaco antiinflamatorio, no esteroideo y un derivado de colchicósido

Info

Publication number
ECSP11011212A
ECSP11011212A EC2011011212A ECSP11011212A ECSP11011212A EC SP11011212 A ECSP11011212 A EC SP11011212A EC 2011011212 A EC2011011212 A EC 2011011212A EC SP11011212 A ECSP11011212 A EC SP11011212A EC SP11011212 A ECSP11011212 A EC SP11011212A
Authority
EC
Ecuador
Prior art keywords
inflammatory
active ingredients
new association
ingredients containing
steroid drug
Prior art date
Application number
EC2011011212A
Other languages
English (en)
Inventor
Praveen Khullar
Mansing Shingte
Shirishbhai Patel
A Suseendharnath
Krishna Raju
Vanga Reddy
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41009626&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP11011212(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of ECSP11011212A publication Critical patent/ECSP11011212A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composición farmacéutica que contiene una asociación de un fármaco antiinflamatorio, no esteroideo y un derivado de colchicósido, estando presentes los ingredientes activos en estado libre o en la forma de una sal.
EC2011011212A 2009-01-22 2011-07-18 Nueva asociación de ingredientes activos que contienen un fármaco antiinflamatorio, no esteroideo y un derivado de colchicósido ECSP11011212A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2009/000071 WO2010084500A1 (en) 2009-01-22 2009-01-22 New combination of active ingredients containing a non steroidal anti inflammatory drug and a colchicoside derivative

Publications (1)

Publication Number Publication Date
ECSP11011212A true ECSP11011212A (es) 2011-08-31

Family

ID=41009626

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2011011212A ECSP11011212A (es) 2009-01-22 2011-07-18 Nueva asociación de ingredientes activos que contienen un fármaco antiinflamatorio, no esteroideo y un derivado de colchicósido

Country Status (21)

Country Link
US (1) US20120052121A1 (es)
EP (1) EP2389173A1 (es)
JP (1) JP5591828B2 (es)
CN (1) CN102665705A (es)
AR (1) AR074521A1 (es)
AU (1) AU2009338480A1 (es)
BR (1) BRPI0924198A2 (es)
CA (1) CA2750457A1 (es)
EA (1) EA201170950A1 (es)
EC (1) ECSP11011212A (es)
IL (1) IL214134A0 (es)
MA (1) MA33055B1 (es)
MX (1) MX2011007814A (es)
PE (1) PE20100560A1 (es)
SG (1) SG173071A1 (es)
TN (1) TN2011000352A1 (es)
TW (1) TWI424850B (es)
UA (1) UA102010C2 (es)
UY (1) UY31856A (es)
WO (1) WO2010084500A1 (es)
ZA (1) ZA201105386B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012173581A1 (en) 2011-03-21 2012-12-20 Ak Kimya Ithalat-Ihracat Ve Sanayii A.S. Thiocolchicoside, etodolac and famotidine combinations
TR201103752A2 (tr) 2011-04-18 2012-11-21 Ak Ki̇mya İthalat-İhracat Ve Sanayi̇i̇ A.Ş. Tiyokolşikozit, diklofenak ve lansoprazol kombinasyonları.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2929M (fr) * 1963-04-11 1964-11-16 S O M A I N Soc De Marques Et Composition pharmaceutique pour le traitement des affections arthritiques et rhumatismales.
US4780463A (en) * 1984-12-26 1988-10-25 Analgesic Associates Analgesic, anti-inflammatory and skeletal muscle relaxant compositions comprising non-steroidal anti-inflammatory drugs and musculoskeletal relaxants and methods of using same
FR2725134B1 (fr) * 1994-10-04 1996-12-20 Lederle Lab Nouvelle association pharmaceutique a base d'ibuprofene et de thiocolchicoside
FR2735369B1 (fr) * 1995-06-13 1997-07-11 Synthelabo Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside
US6235311B1 (en) * 1998-03-18 2001-05-22 Bristol-Myers Squibb Company Pharmaceutical composition containing a combination of a statin and aspirin and method
US6197347B1 (en) * 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
KR102109867B1 (ko) * 2006-01-24 2020-05-13 안선 바이오파르마, 아이엔씨. 고분자 미소 구체들의 조제를 위한 기술
TR200703092A1 (tr) * 2007-05-08 2008-12-22 SANOVEL �LA� SAN. VE TiC. A.�. Flurbiprofen ve kas gevşetici kombinasyonları
AU2009207580B8 (en) * 2008-01-25 2014-06-12 Laboratoires Majorelle Combination of oral medicaments bonded by a wrapping

Also Published As

Publication number Publication date
WO2010084500A1 (en) 2010-07-29
JP5591828B2 (ja) 2014-09-17
IL214134A0 (en) 2011-08-31
UY31856A (es) 2010-08-31
TN2011000352A1 (en) 2013-03-27
MX2011007814A (es) 2011-11-29
MA33055B1 (fr) 2012-02-01
BRPI0924198A2 (pt) 2016-02-16
AU2009338480A1 (en) 2011-08-11
CA2750457A1 (en) 2010-07-29
US20120052121A1 (en) 2012-03-01
UA102010C2 (ru) 2013-05-27
CN102665705A (zh) 2012-09-12
ZA201105386B (en) 2012-09-26
TWI424850B (zh) 2014-02-01
EA201170950A1 (ru) 2012-02-28
SG173071A1 (en) 2011-08-29
EP2389173A1 (en) 2011-11-30
TW201028155A (en) 2010-08-01
PE20100560A1 (es) 2010-08-16
AR074521A1 (es) 2011-01-26
JP2012515764A (ja) 2012-07-12

Similar Documents

Publication Publication Date Title
CL2011000170A1 (es) Composicion farmaceutica solida y estabilizada que comprende un ingrediente farmaceuticamente activo, oxido de titanio y un plastificante; procedimiento para estabilizar la composicion farmaceutica durante una irradiacion luminosa.
CO6511251A2 (es) Compuestos quimicos
CL2012000626A1 (es) Composición farmacéutica oral de liberación sostenida, que comprende dentro de una forma de dosificación única, (i) una matriz hidrofílica, (ii) una cantidad terapéuticamente eficaz de un compuesto no opioide que contiene amina, (iii) una sal de un fármaco aine, y (iv) opcionalmente un surfactante aniónico.
UY30166A1 (es) Nuevas arildihidroisoquinolinonas sustituidas con azaciclilo, procedimiento para su preparación y su uso como medicamentos
EA201200550A1 (ru) Фармацевтические композиции, включающие bi-1356 и метформин
EA201071204A1 (ru) Применение дронедарона для приготовления лекарственного средства для применения в предотвращении госпитализации в кардиологическое отделение или смертности
UY33201A (es) Compuestos de pirazol como antagonistas de crth2.
CL2008003284A1 (es) Compuestos derivados de 4-bencilamino-1-carboxiacil-piridina, inhibidores cetp; composicion farmaceutica que los comprende; combinacion farmaceutica; y uso en el tratamiento de enfermedades metabolicas, ateroesclerosis y cardiovasculares, entre otras.
UY30163A1 (es) Nuevas ariltienopirimidinonas sustituidas con azaciclilo, procedimiento para su preparación y su uso como medicamentos
CR20110680A (es) Sulfonamidas heterociclicas, usos y composiciones farmacéuticas de las mismas
DOP2010000134A (es) Algunos derivados de 2-pirazinona como inhibidores de elastasa de los neutrofilos
ECSP11011307A (es) Comprimidos para terapia de combinacion
UY30165A1 (es) Nuevas arildihidroisoquinolinonas sustituidas con aminolcoholes, procedimiento para su preparación y su uso como medicamentos
UY31788A (es) Formulación farmacéutica sólida con liberación retardada
DOP2012000050A (es) Nuevas composiciones de 1-[2-(2,4-dimetil-fenilsulfanil)-fenil] piperazina
CR11744A (es) Formulacion liquida para deferiprona con gusto agradable al paladar
CL2009001841A1 (es) Uso de una composición de liberación sostenida de 4-aminopiridina para preparar un medicamento útil para tratar esclerosis multiple en un sujeto.
UY32299A (es) Composiciones farmacéuticas líquidas
AR082215A1 (es) Composicion farmaceutica agradable al paladar
ECSP13012832A (es) Compuestos de pirazol como antagonistas de crth2
UY31000A1 (es) Oxoisoxazoles como inhibidores de lipasas y fosfolipasas
ECSP11011212A (es) Nueva asociación de ingredientes activos que contienen un fármaco antiinflamatorio, no esteroideo y un derivado de colchicósido
ES2530436T3 (es) Combinación
ES2561813T3 (es) Aplicación tópica de nimesulida y tiocolchicósido
AR067351A1 (es) Combinacion de picotamida con nafronil